Literature DB >> 31085013

Diagnostic value of neutrophil CD64 combined with CRP for neonatal sepsis: A meta-analysis.

Yan Song1, Yuanchun Chen1, Xue Dong1, Xiaohua Jiang2.   

Abstract

BACKGROUND: Sepsis is the leading cause of morbidity and mortality in newborns. CD64 combined with c-reactive protein (CRP) could improve the sensitivity and specificity of neonatal sepsis diagnosis, but the results were still controversial. Therefore, this meta-analysis was conducted to clarify the importance of CD64 combined with CRP in the diagnosis of neonatal sepsis.
METHODS: The researches published as of December 24, 2018 were comprehensively searched in PubMed, Embase (included Embase and Medline), the Cochrane Library and Web of Science. Totally, 8 articles were included, involving 1114 objects. Statistical calculations were performed using Stata14.0 and Review Manager 5.3.
RESULTS: The diagnostic accuracy of all included studies was pooled as follows: sensitivity, 0.95 (95% CI: 0.86-0.98); specificity, 0.86 (95% CI: 0.74-0.93); positive likelihood ratio (PLR), 6.8 (95% CI: 3.50-13.20); negative likelihood ratio (NLR), 0.06 (95% CI: 0.02-0.18); diagnostic odds ratio (DOR), 118.0 (95% CI: 25.00-549.00), and the area under the curve (AUC) was 0.96 (95% CI: 0.94-0.97). It was found that heterogeneity was not caused by threshold effect (P = 0.16), but the results of sensitivity (I2 = 87.57%) and specificity (I2 = 89.07%) analyses indicated significant heterogeneity between studies.
CONCLUSIONS: The combined application of CD64 and CRP improved the accuracy of neonatal sepsis diagnosis.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  CRP; Diagnostic; Meta-analysis; Neonatal sepsis; Neutrophil CD64

Mesh:

Substances:

Year:  2019        PMID: 31085013     DOI: 10.1016/j.ajem.2019.05.001

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  5 in total

1.  Validation of a Quick Flow Cytometry-Based Assay for Acute Infection Based on CD64 and CD169 Expression. New Tools for Early Diagnosis in COVID-19 Pandemic.

Authors:  Alejandra Comins-Boo; Maria Gutiérrez-Larrañaga; Adriel Roa-Bautista; Sandra Guiral Foz; Mónica Renuncio García; Elena González López; Juan Irure Ventura; María Carmen Fariñas-Álvarez; David San Segundo; Marcos López Hoyos
Journal:  Front Med (Lausanne)       Date:  2021-03-23

2.  The Accuracy of 16S rRNA Polymerase Chain Reaction for the Diagnosis of Neonatal Sepsis: A Meta-Analysis.

Authors:  Ying Wang; Jingyi Zhao; Yinhui Yao; Lan Yang; Dan Zhao; Shiquan Liu
Journal:  Biomed Res Int       Date:  2021-05-12       Impact factor: 3.411

Review 3.  Future Biomarkers for Infection and Inflammation in Febrile Children.

Authors:  Judith Zandstra; Ilse Jongerius; Taco W Kuijpers
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

Review 4.  Host Diagnostic Biomarkers of Infection in the ICU: Where Are We and Where Are We Going?

Authors:  Aaron J Heffernan; Kerina J Denny
Journal:  Curr Infect Dis Rep       Date:  2021-02-12       Impact factor: 3.725

5.  Diagnostic performance of Neutrophil CD64 index, procalcitonin, and C-reactive protein for early sepsis in hematological patients.

Authors:  Yu-Xi Shang; Zhi Zheng; Min Wang; Hui-Xia Guo; Yi-Juan Chen; Yue Wu; Xing Li; Qian Li; Jian-Ying Cui; Xiao-Xiao Ren; Li-Ru Wang
Journal:  World J Clin Cases       Date:  2022-03-06       Impact factor: 1.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.